Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

Novak J, Barratt J, Julian BA, Renfrow MB.

Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016. Review.

PMID:
30177018
2.

IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.

Contrib Nephrol. 2007;157:134-8. Review.

PMID:
17495451
3.

Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.

Adv Otorhinolaryngol. 2011;72:60-3. doi: 10.1159/000324607. Epub 2011 Aug 18. Review.

PMID:
21865691
4.

Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.

Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.

J Immunol Res. 2014;2014:197548. doi: 10.1155/2014/197548. Epub 2014 Jul 23. Review.

5.

Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Novak J, Julian BA, Mestecky J, Renfrow MB.

Semin Immunopathol. 2012 May;34(3):365-82. doi: 10.1007/s00281-012-0306-z. Epub 2012 Mar 21. Review.

PMID:
22434325
6.

IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Novak J, Julian BA, Tomana M, Mestecky J.

Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009. Review.

7.

Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.

Biochemistry. 2010 Jul 13;49(27):5671-82. doi: 10.1021/bi9019498.

8.

The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.

Barratt J, Smith AC, Feehally J.

Nephrology (Carlton). 2007 Jun;12(3):275-84. Review.

PMID:
17498123
9.

[IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].

Xie L, Wang L, Huang J, Fan J.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):227-30. Review. Chinese.

PMID:
20337060
10.

Pathogenesis of IgA nephropathy.

Lai KN.

Nat Rev Nephrol. 2012 Mar 20;8(5):275-83. doi: 10.1038/nrneph.2012.58. Review.

PMID:
22430056
11.

Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.

Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M.

Kidney Blood Press Res. 2018;43(2):350-359. doi: 10.1159/000487903. Epub 2018 Mar 6.

12.

IgA nephropathy enigma.

Mestecky J, Novak J, Moldoveanu Z, Raska M.

Clin Immunol. 2016 Nov;172:72-77. doi: 10.1016/j.clim.2016.07.011. Epub 2016 Jul 18. Review.

13.

IgA nephropathy: an update.

Julian BA, Novak J.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):171-9. Review.

PMID:
15202611
14.

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.

J Clin Invest. 1999 Jul;104(1):73-81.

15.

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.

Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.

PLoS One. 2018 Jan 11;13(1):e0190967. doi: 10.1371/journal.pone.0190967. eCollection 2018.

16.

The pathophysiology of IgA nephropathy.

Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA.

J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23. Review.

17.

Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants.

Dicker M, Maresch D, Strasser R.

Bioengineered. 2016 Nov;7(6):484-489. doi: 10.1080/21655979.2016.1201251. Epub 2016 Jun 22.

18.

Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.

Narita I, Gejyo F.

Clin Exp Nephrol. 2008 Oct;12(5):332-338. doi: 10.1007/s10157-008-0054-5. Epub 2008 Apr 12. Review.

PMID:
18404247
19.

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.

Kidney Blood Press Res. 2008;31(1):29-37. doi: 10.1159/000112922. Epub 2008 Jan 8. Review.

20.

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.

Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.

BMC Nephrol. 2017 Sep 29;18(1):301. doi: 10.1186/s12882-017-0722-3.

Supplemental Content

Support Center